Explore the innovative subcutaneous delivery of isatuximab for multiple myeloma, enhancing patient experience and treatment ...

Karolinska University Hospital has, for the first time in Sweden, begun preparations to treat a patient with multiple myeloma ...

Karolinska University Hospital has, for the first time in Sweden, begun preparations to treat a patient with multiple myeloma ...

CAR T-cell therapy may cure up to 40% of patients with lymphoma and is an option for those who can’t receive transplants, ...

Around 1,500 people with multiple myeloma will benefit from belantamab mafodotin, used in combination with bortezomib and ...

The agency removed some onerous requirements for the complex cancer drugs and reduced restrictions on patients’ ...

A new four-drug combination is highly effective and safe in patients with newly diagnosed multiple myeloma, according to data presented at the annual meeting of the American Society of Clinical ...

In fact, 1 in 5 myeloma patients are diagnosed with the disease only because they’ve gone to the doctor for routine medical exams and had lab tests that revealed telltale changes in blood or ...

According to clinical guidelines, high-risk myeloma patients should receive intensified treatment regimens. However, heterogeneity in cli ...

Early results from the MagnetisMM-6 trial reveal promising efficacy of elranatamab, daratumumab, and lenalidomide in treating ...

Multiple Myeloma Research. Our multiple myeloma research begins in the laboratory, where we study the biology of myeloma cells and develop potential new drugs and immunotherapies. It also includes ...